Considerations in the design of clinical trials for cognitive aging.

The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
Eric M ReimanPaul S Aisen

Abstract

What will it take to develop interventions for the treatment of age-related cognitive decline? Session V of the Summit provided perspectives on the design of clinical trials to evaluate promising but unproven interventions, and some of the steps needed to accelerate the discovery and evaluation of promising treatments. It considered strategies to further characterize the biological and cognitive changes associated with normal aging and their translation into the development of new treatments. It provided regulatory, scientific, and clinical perspectives about neurocognitive aging treatments, their potential benefits and risks, and the strategies and endpoints needed to evaluate them in the most rapid, rigorous, and clinically meaningful way. It considered lessons learned from the study of Alzheimer's disease, the promising roles of biomarkers in neurocognitive aging research, and ways to help galvanize the scientific study and treatment of neurocognitive aging.

References

May 1, 2004·Proceedings of the National Academy of Sciences of the United States of America·Scott A SmallCarol A Barnes
Jun 23, 2006·Neuroreport·Gene E AlexanderJames R Moeller
Oct 21, 2006·Science·Andreas PapassotiropoulosDominique J-F de Quervain
Mar 21, 2009·Trends in Pharmacological Sciences·Roberta Diaz Brinton
Jul 31, 2009·Dementia and Geriatric Cognitive Disorders·Jared F BengeRachelle S Doody
Jan 20, 2010·Lancet Neurology·Clifford R JackJohn Q Trojanowski
Jul 9, 2011·Menopause : the Journal of the North American Menopause Society·Liqin ZhaoRoberta D Brinton

❮ Previous
Next ❯

Citations

May 29, 2014·Journal of the International Neuropsychological Society : JINS·Shannon K RungeRoger A Dixon
Jun 9, 2014·Prostaglandins, Leukotrienes, and Essential Fatty Acids·C JoffreS Laye
Jun 14, 2015·Trends in Molecular Medicine·Joseph A McQuailJennifer L Bizon
Sep 10, 2014·Psychiatry Research·Auriel A WilletteUNKNOWN Alzheimer׳s Disease Neuroimaging Initiative
Dec 24, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Charles C CaldwellRoberta Diaz Brinton
Jun 8, 2017·Frontiers in Neuroscience·Maja MustapicDimitrios Kapogiannis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics
Anna C NeedDavid B Goldstein
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences
Gerda G Fillenbaum
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists
Brandon E Gavett, Julie E Horwitz
© 2021 Meta ULC. All rights reserved